Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 66 for CHRONIC LYMPHOCYTIC LEUKEMIA

Edit search filters
  1. A Study To Investigate The Safety And Tolerability Of REGN1979 In Patients With CD20+ B-Cell Malignancies

    Rochester, MN

  2. A Study Of CG-806 In Patients With Relapsed Or Refractory CLL/SLL Or Non-Hodgkin's Lymphomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003)

    Rochester, MN

  4. Cholecalciferol In Improving Survival In Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Study Of Bcl-2 Inhibitor BGB-11417 In Participants With Mature B-Cell Malignancies

    Rochester, MN

  6. A Dose-Escalation And Expansion Study Of Tacabrutideg (BGB-16673) In Participants With B-Cell Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. CD19-Directed CAR-T Cell Therapy For The Treatment Of Relapsed/​Refractory B Cell Malignancies

    Rochester, MN

  8. Study Of Rezafungin Compared To Standard Antimicrobial Regimen For Prevention Of Invasive Fungal Diseases In Adults Undergoing Allogeneic Blood And Marrow Transplantation (ReSPECT)

    Rochester, MN

  9. Study Of BMF-219, In Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), And Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL)

    Jacksonville, FL

  10. A Study Of APG-3288 In Relapsed/Refractory Blood Cancers

    Jacksonville, FL

.

Mayo Clinic Footer